Hu G, Wang X, Meng L, Li J, Xu H, Wu D
Front Cardiovasc Med. 2022; 9:948909.
PMID: 36035950
PMC: 9405420.
DOI: 10.3389/fcvm.2022.948909.
Itano Y, Sobajima H, Ohashi N, Shibata T, Fujiya A, Nagata T
J Diabetes Investig. 2020; 12(6):998-1006.
PMID: 33034138
PMC: 8169355.
DOI: 10.1111/jdi.13428.
Reilly D, Breyer M
Clin J Am Soc Nephrol. 2020; 15(9):1342-1351.
PMID: 32193173
PMC: 7480559.
DOI: 10.2215/CJN.11070919.
Yu L, Wu M, Hou P, Zhang H
BMC Nephrol. 2020; 21(1):69.
PMID: 32111189
PMC: 7047355.
DOI: 10.1186/s12882-020-01725-9.
Li S, Yang Y, Huang L, Kong M, Yang Z
Mol Med Rep. 2019; 19(5):4364-4376.
PMID: 30942416
PMC: 6472135.
DOI: 10.3892/mmr.2019.10110.
Inhibitor binding mode and allosteric regulation of Na-glucose symporters.
Bisignano P, Ghezzi C, Jo H, Polizzi N, Althoff T, Kalyanaraman C
Nat Commun. 2018; 9(1):5245.
PMID: 30532032
PMC: 6286348.
DOI: 10.1038/s41467-018-07700-1.
An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes.
Messana J, Schwartz S, Townsend R
Vasc Health Risk Manag. 2017; 13:43-54.
PMID: 28255241
PMC: 5322811.
DOI: 10.2147/VHRM.S105721.
The renal effects of SGLT2 inhibitors and a mini-review of the literature.
Andrianesis V, Glykofridi S, Doupis J
Ther Adv Endocrinol Metab. 2017; 7(5-6):212-228.
PMID: 28203358
PMC: 5298360.
DOI: 10.1177/2042018816676239.
Glycosuria and Renal Outcomes in Patients with Nondiabetic Advanced Chronic Kidney Disease.
Hung C, Lin H, Jia-Jung Lee , Lim L, Chiu Y, Chiang H
Sci Rep. 2016; 6:39372.
PMID: 28008953
PMC: 5180243.
DOI: 10.1038/srep39372.
Novel mutation contributes to familial renal glucosuria: Abnormal expression in renal tissues.
Yu L, Hou P, Liu G, Zhang H
Exp Ther Med. 2016; 12(2):649-652.
PMID: 27446256
PMC: 4950299.
DOI: 10.3892/etm.2016.3388.
Decreased expression and function of sodium-glucose co-transporter 2 from a novel C-terminal mutation: a case report.
Yu L, Xu Q, Hou P, Zhang H
BMC Nephrol. 2016; 17:31.
PMID: 27000029
PMC: 4800764.
DOI: 10.1186/s12882-016-0244-4.
Influence of Familial Renal Glycosuria Due to Mutations in the SLC5A2 Gene on Changes in Glucose Tolerance over Time.
Ottosson-Laakso E, Tuomi T, Forsen B, Gullstrom M, Groop P, Groop L
PLoS One. 2016; 11(1):e0146114.
PMID: 26735923
PMC: 4703216.
DOI: 10.1371/journal.pone.0146114.
LP-925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT1 and SGLT2.
Powell D, Smith M, Doree D, Harris A, Xiong W, Mseeh F
Pharmacol Res Perspect. 2015; 3(2):e00129.
PMID: 26038705
PMC: 4448982.
DOI: 10.1002/prp2.129.
Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences.
Gallo L, Wright E, Vallon V
Diab Vasc Dis Res. 2015; 12(2):78-89.
PMID: 25616707
PMC: 5886707.
DOI: 10.1177/1479164114561992.
Drug-induced acid-base disorders.
Kitterer D, Schwab M, Alscher M, Braun N, Latus J
Pediatr Nephrol. 2014; 30(9):1407-23.
PMID: 25370778
DOI: 10.1007/s00467-014-2958-5.
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
Vallon V, Gerasimova M, Rose M, Masuda T, Satriano J, Mayoux E
Am J Physiol Renal Physiol. 2013; 306(2):F194-204.
PMID: 24226524
PMC: 3920018.
DOI: 10.1152/ajprenal.00520.2013.
Pathophysiology of the diabetic kidney.
Vallon V, Komers R
Compr Physiol. 2013; 1(3):1175-232.
PMID: 23733640
PMC: 6029262.
DOI: 10.1002/cphy.c100049.
Familial renal glucosuria: a clinicogenetic study of 23 additional cases.
Lee H, Han K, Park H, Shin J, Kim C, Namgung M
Pediatr Nephrol. 2012; 27(7):1091-5.
PMID: 22314875
DOI: 10.1007/s00467-012-2109-9.
Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences.
Sabolic I, Vrhovac I, Balen Eror D, Gerasimova M, Rose M, Breljak D
Am J Physiol Cell Physiol. 2012; 302(8):C1174-88.
PMID: 22262063
PMC: 3774553.
DOI: 10.1152/ajpcell.00450.2011.
Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes.
Tahrani A, Barnett A
Diabetes Ther. 2011; 1(2):45-56.
PMID: 22127745
PMC: 3138480.
DOI: 10.1007/s13300-010-0007-3.
